Cyclosporin microemulsion for treatment of severe psoriasis: Study of 9 cases;Ciclosporina microemulsão no tratamento da Psoríase grave: Estudo de nove casos

Anais Brasileiros de Dermatologia

Volumn 77, Issue 1, 2002, Pages 79-86

  Schwartz, Joel ^a   Magnabosco, Elisiane Marcolin ^a   Cavalcante Oliveira, Marco Túlio ^a   Miorin de Abreu, Maria Luísa ^a   Biasi, Tatiana Basso ^a  

^a NONE   (Brazil)

Author keywords

Psoriasis

Indexed keywords

ANTIPSORIASIS AGENT; CORTICOSTEROID; CYCLOSPORIN; DITHRANOL; METHOTREXATE; METOCLOPRAMIDE; SALICYLIC ACID; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; DISEASE SEVERITY; DRUG ABSORPTION; DRUG EFFICACY; DRUG FORMULATION; DRUG INDUCED DISEASE; DRUG MECHANISM; DRUG RESPONSE; FEMALE; HUMAN; LIQUOR CARBONIS DETERGENS; LIVER TOXICITY; LYMPHOCYTE FUNCTION; MALE; MEDICAL LITERATURE; MICROEMULSION; PHOTOTHERAPY; PSORIASIS; REMISSION; TOPICAL TREATMENT;

EID: 0036217169     PISSN: 03650596     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Cyclosporine nephrotoxicity: Implications for dermatology
2. Biovailability and pharmacokinetics of cyclosporine formulations: Neoral® vs Sandimmune®
3. Severe psoriasis-oral therapy with a new retinoid
4. Systemic and local administration of cyclosporine in the treatment of psoriasis
5. Biological effects of cyclosporin A: A new antilymphocytic agent
6. Cyclosporine consensus conference: With emphasis on the treatment of psoriasis
7. Initiating Neoral® therapy
8. Consensus conference on cyclosporin A microemulsion for psoriasis, June 1996
9. Potential drug interactions with cyclosporine
10. Ciclosporina A em psoríase
11. Safety issues with cyclosporine
12. Management of patients and side effects during cyclosporine therapy for cutaneous disorders
13. Cyclosporine
14. Individualized short-course cyclosporine therapy in psoriasis
15. Maintenance therapy with Neoral®
16. Advances in psoriasis therapy
17. Treatment of psoriasis with intermittent short course cyclosporin (Neoral®). A multicentre study
18. Low-dose cyclosporine A improves in Latin America
19. Neoral in psoriasis therapy: Toward a new perspective
20. Psoriasis therapy after remission: The next step
21. Efficacy of cyclosporina (CyA) in psoriasis: An overview of dose/response, indications, contraindications and side-effects